{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:36:02Z","timestamp":1791412562071,"version":"4.3.3"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T00:00:00Z","timestamp":1751673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T00:00:00Z","timestamp":1751673600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lung"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Ventilator-associated pneumonia (VAP) is a common ICU complication linked to high morbidity and mortality. Inhaled antibiotics may offer targeted prophylaxis, but their effectiveness has shown mixed results. This study aims to further evaluate whether inhaled antibiotics reduce VAP incidence and ICU mortality through a systematic review and meta-analysis of the most updated available evidence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A systematic review was conducted following PRISMA 2020 guidelines. Multiple databases were searched for studies published up to November 14, 2024. Ten studies including 2876 patients (1485 intervention; 1391 control) met inclusion criteria. A random-effects meta-analysis was performed to estimate pooled risk ratios (RR) for VAP incidence and ICU mortality. Risk of bias was assessed using ROBINS-I and certainty of evidence via GRADE.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Inhaled antibiotics significantly reduced the incidence of VAP compared to controls (RR\u2009=\u20090.67; 95% CI: 0.58\u20130.77;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), but showed no significant effect on ICU mortality (RR\u2009=\u20090.92; 95% CI: 0.79\u20131.06;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.25). Moderate heterogeneity was observed in VAP outcomes (\n                      <jats:italic>I<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      \u2009=\u200946.8%), while mortality analysis showed no heterogeneity. Funnel plot analysis suggested minimal publication bias, and GRADE rated the evidence as moderate in certainty.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Inhaled antibiotics significantly reduce VAP incidence but show no clear mortality benefit. While promising for prevention, their survival impact remains uncertain. Clinical use should consider patient context and microbial patterns for targeted approach. Future research should identify high-risk subgroups, assess long-term outcomes, and evaluate antibiotic resistance.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00408-025-00827-1","type":"journal-article","created":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T15:03:05Z","timestamp":1751727785000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Prophylactic Inhaled Antibiotics for Ventilator-Associated Pneumonia: A Systematic Review and Meta-Analysis of Incidence and Mortality Outcomes"],"prefix":"10.1007","volume":"203","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9176-3510","authenticated-orcid":false,"given":"Carlos","family":"Valladares","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1198-669X","authenticated-orcid":false,"given":"Bryan","family":"Gregory","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7810-813X","authenticated-orcid":false,"given":"Sheilabi","family":"Seeburun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0722-827X","authenticated-orcid":false,"given":"Ahmed Dawood","family":"Al Mahrizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9775-5919","authenticated-orcid":false,"given":"Shreya","family":"Shambhavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3388-1899","authenticated-orcid":false,"given":"Adam","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7414-3974","authenticated-orcid":false,"given":"Wajahat","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,5]]},"reference":[{"key":"827_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2023.154284","volume":"75","author":"J Johnstone","year":"2023","unstructured":"Johnstone J, Muscedere J, Dionne J et al (2023) Definitions, rates and associated mortality of ICU-acquired pneumonia: a multicenter cohort study. J Crit Care 75:154284. https:\/\/doi.org\/10.1016\/j.jcrc.2023.154284","journal-title":"J Crit Care"},{"issue":"2","key":"827_CR2","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1378\/chest.14-0610","volume":"147","author":"A Ego","year":"2015","unstructured":"Ego A, Preiser JC, Vincent JL (2015) Impact of diagnostic criteria on the incidence of ventilator-associated pneumonia. Chest 147(2):347\u2013355. https:\/\/doi.org\/10.1378\/chest.14-0610","journal-title":"Chest"},{"key":"827_CR3","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.jcrc.2017.09.019","volume":"43","author":"FCC P\u00f3voa","year":"2018","unstructured":"P\u00f3voa FCC, Cardinal-Fernandez P, Maia IS, Reboredo MM, Pinheiro BV (2018) Effect of antibiotics administered via the respiratory tract in the prevention of ventilator-associated pneumonia: a systematic review and meta-analysis. J Crit Care 43:240\u2013245. https:\/\/doi.org\/10.1016\/j.jcrc.2017.09.019","journal-title":"J Crit Care"},{"issue":"7","key":"827_CR4","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1164\/ajrccm.165.7.2105078","volume":"165","author":"J Chastre","year":"2002","unstructured":"Chastre J, Fagon JY (2002) Ventilator-associated pneumonia. Am J Respir Crit Care Med 165(7):867\u2013903. https:\/\/doi.org\/10.1164\/ajrccm.165.7.2105078","journal-title":"Am J Respir Crit Care Med"},{"key":"827_CR5","doi-asserted-by":"publisher","unstructured":"Mumtaz H, Saqib M, Khan W et al (2023) Ventilator associated pneumonia in intensive care unit patients: a systematic review.\u00a0Ann Med Surg (Lond) 85(6):2932\u20132939. Published 2023 May 12. https:\/\/doi.org\/10.1097\/MS9.0000000000000836","DOI":"10.1097\/MS9.0000000000000836"},{"issue":"11","key":"827_CR6","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1001\/jama.1996.03530350048033","volume":"275","author":"J Fagon","year":"1996","unstructured":"Fagon J, Chastre J, Vuagnat A, Trouillet J, Novara A, Gibert C (1996) Nosocomial pneumonia and mortality among patients in intensive care units. JAMA 275(11):866\u2013869. https:\/\/doi.org\/10.1001\/jama.1996.03530350048033","journal-title":"JAMA"},{"issue":"10","key":"827_CR7","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1097\/01.ccm.0000181731.53912.d9","volume":"33","author":"N Safdar","year":"2005","unstructured":"Safdar N, Dezfulian C, Collard HR, Saint S (2005) Clinical and economic consequences of ventilator-associated pneumonia: a systematic review. Crit Care Med 33(10):2184\u20132193. https:\/\/doi.org\/10.1097\/01.ccm.0000181731.53912.d9","journal-title":"Crit Care Med"},{"issue":"3","key":"827_CR8","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1086\/664049","volume":"33","author":"MH Kollef","year":"2012","unstructured":"Kollef MH, Hamilton CW, Ernst FR (2012) Economic impact of ventilator-associated pneumonia in a large matched cohort. Infect Control Hosp Epidemiol 33(3):250\u2013256. https:\/\/doi.org\/10.1086\/664049","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"4","key":"827_CR9","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.ccm.2018.08.002","volume":"39","author":"ML Metersky","year":"2018","unstructured":"Metersky ML, Kalil AC (2018) Management of ventilator-associated pneumonia: guidelines. Clin Chest Med 39(4):797\u2013808. https:\/\/doi.org\/10.1016\/j.ccm.2018.08.002","journal-title":"Clin Chest Med"},{"issue":"11","key":"827_CR10","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1007\/s10096-016-2703-z","volume":"36","author":"D Koulenti","year":"2017","unstructured":"Koulenti D, Tsigou E, Rello J (2017) Nosocomial pneumonia in 27 ICUs in Europe: perspectives from the EU-VAP\/CAP study. Eur J Clin Microbiol Infect Dis 36(11):1999\u20132006. https:\/\/doi.org\/10.1007\/s10096-016-2703-z","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"827_CR11","doi-asserted-by":"publisher","unstructured":"Steen J, Vansteelandt S, De Bus L et al (2021) Attributable mortality of ventilator-associated pneumonia. Replicating findings, revisiting methods.\u00a0Ann Am Thorac Soc 18(5):830\u2013837. https:\/\/doi.org\/10.1513\/AnnalsATS.202004-385OC","DOI":"10.1513\/AnnalsATS.202004-385OC"},{"key":"827_CR12","doi-asserted-by":"publisher","unstructured":"Mergulh\u00e3o P, Pereira JG, Fernandes AV et al (2024) Epidemiology and burden of ventilator-associated pneumonia among adult intensive care unit patients: a Portuguese, multicenter, retrospective study (eVAP-PT Study).\u00a0Antibiotics (Basel) 13(4):290. Published 2024 Mar 22. https:\/\/doi.org\/10.3390\/antibiotics13040290","DOI":"10.3390\/antibiotics13040290"},{"issue":"22","key":"827_CR13","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1001\/jama.2016.16226","volume":"316","author":"ML Metersky","year":"2016","unstructured":"Metersky ML, Wang Y, Klompas M, Eckenrode S, Bakullari A, Eldridge N (2016) Trend in ventilator-associated pneumonia rates between 2005 and 2013. JAMA 316(22):2427\u20132429. https:\/\/doi.org\/10.1001\/jama.2016.16226","journal-title":"JAMA"},{"key":"827_CR14","doi-asserted-by":"publisher","unstructured":"He Q, Wang W, Zhu S et al (2021) The epidemiology and clinical outcomes of ventilator-associated events among 20,769 mechanically ventilated patients at intensive care units: an observational study.\u00a0Crit Care 25(1):44. Published 2021 Feb 2. https:\/\/doi.org\/10.1186\/s13054-021-03484-x","DOI":"10.1186\/s13054-021-03484-x"},{"key":"827_CR15","doi-asserted-by":"publisher","unstructured":"Myrianthefs P, Zakynthinos GE, Tsolaki V, Makris D (2023) Aerosolized Antibiotics to Manage ventilator-associated infections: a comprehensive review.\u00a0Antibiotics (Basel) 12(5):801. Published 2023 Apr 23. https:\/\/doi.org\/10.3390\/antibiotics12050801","DOI":"10.3390\/antibiotics12050801"},{"issue":"23","key":"827_CR16","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1001\/jama.2012.6445","volume":"307","author":"NP O'Grady","year":"2012","unstructured":"O\u2019Grady NP, Murray PR, Ames N (2012) Preventing ventilator-associated pneumonia: does the evidence support the practice? JAMA 307(23):2534\u20132539. https:\/\/doi.org\/10.1001\/jama.2012.6445","journal-title":"JAMA"},{"issue":"7","key":"827_CR17","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1097\/CCM.0000000000003136","volume":"46","author":"C Pileggi","year":"2018","unstructured":"Pileggi C, Mascaro V, Bianco A, Nobile CGA, Pavia M (2018) Ventilator bundle and its effects on mortality among ICU patients: a meta-analysis. Crit Care Med 46(7):1167\u20131174. https:\/\/doi.org\/10.1097\/CCM.0000000000003136","journal-title":"Crit Care Med"},{"key":"827_CR18","doi-asserted-by":"publisher","unstructured":"Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.\u00a0BMJ 372:n71. Published 2021 Mar 29. https:\/\/doi.org\/10.1136\/bmj.n71","DOI":"10.1136\/bmj.n71"},{"key":"827_CR19","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","volume":"5","author":"M Ouzzani","year":"2016","unstructured":"Ouzzani M, Hammady H, Fedorowicz Z et al (2016) Rayyan\u2014a web and mobile app for systematic reviews. Syst Rev 5:210. https:\/\/doi.org\/10.1186\/s13643-016-0384-4","journal-title":"Syst Rev"},{"key":"827_CR20","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jcrc.2016.04.005","volume":"34","author":"H Bandeshe","year":"2016","unstructured":"Bandeshe H, Boots R, Dulhunty J et al (2016) Is inhaled prophylactic heparin useful for prevention and management of pneumonia in ventilated ICU patients?: The IPHIVAP investigators of the Australian and New Zealand Intensive Care Society Clinical Trials Group. J Crit Care 34:95\u2013102. https:\/\/doi.org\/10.1016\/j.jcrc.2016.04.005","journal-title":"J Crit Care"},{"key":"827_CR21","doi-asserted-by":"publisher","unstructured":"Ghahremani-Chabok A, Bagheri-Nesami M, Shorofi SA, Mousavinasab SN, Gholipour-Baradari A, Saeedi M (2021) The effects of thymus vulgaris inhalation therapy on airway status and oxygen saturation of patients under mechanical ventilation: a randomized clinical trial. Adv Integr Med 8(2). https:\/\/doi.org\/10.1016\/j.aimed.2020.08.007","DOI":"10.1016\/j.aimed.2020.08.007"},{"key":"827_CR22","unstructured":"Karimpour H, Hematpour B, Mohammadi S, Aminisaman J, Mirzaei M, Kawyannejad R. Effect of nebulized eucalyptus for preventing ventilator-associated pneumonia in patients under mechanical ventilation: a randomized double blind clinical trial (1078\u20136791 (Print))"},{"key":"827_CR23","doi-asserted-by":"publisher","unstructured":"Khorvash F, Mohajeri F, Farsaei S et al (2021) Management of ventilator-associated pneumonia: a comparison of two therapeutic approaches due to multidrug-resistance Acinetobacter; a controlled clinical trial study. Immunopathologia Persa 9(2). https:\/\/doi.org\/10.34172\/ipp.2022.16210","DOI":"10.34172\/ipp.2022.16210"},{"issue":"10","key":"827_CR24","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1056\/NEJM197509042931003","volume":"293","author":"TW Feeley","year":"1975","unstructured":"Feeley TW, Du Moulin GC, Hedley-Whyte J, Bushnell LS, Gilbert JP, Feingold DS (1975) Aerosol polymyxin and pneumonia in seriously ill patients. N Engl J Med 293(10):471\u2013475. https:\/\/doi.org\/10.1056\/NEJM197509042931003","journal-title":"N Engl J Med"},{"issue":"6","key":"827_CR25","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1183\/13993003.02235-2014","volume":"46","author":"M Karvouniaris","year":"2015","unstructured":"Karvouniaris M, Makris D, Zygoulis P et al (2015) Nebulised colistin for ventilator-associated pneumonia prevention. Eur Respir J 46(6):1732\u20131739. https:\/\/doi.org\/10.1183\/13993003.02235-2014","journal-title":"Eur Respir J"},{"issue":"6","key":"827_CR26","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1378\/chest.65.6.650","volume":"65","author":"J Klastersky","year":"1974","unstructured":"Klastersky J, Huysmans E, Weerts D, Hensgens C, Daneau D (1974) Endotracheally administered gentamicin for the prevention of infections of the respiratory tract in patients with tracheostomy: a double-blind study. Chest 65(6):650\u2013654. https:\/\/doi.org\/10.1378\/chest.65.6.650","journal-title":"Chest"},{"key":"827_CR27","doi-asserted-by":"publisher","unstructured":"Klick JM, du Moulin GC, Hedley-Whyte J, Teres D, Bushnell LS, Feingold DS (1975) Prevention of gram-negative bacillary pneumonia using polymyxin aerosol as prophylaxis. II. Effect on the incidence of pneumonia in seriously ill patients.\u00a0J Clin Invest 55(3):514\u2013519. https:\/\/doi.org\/10.1172\/JCI107957","DOI":"10.1172\/JCI107957"},{"issue":"Suppl 1","key":"827_CR28","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.1007\/BF01752973","volume":"18","author":"H Lode","year":"1992","unstructured":"Lode H, H\u00f6ffken G, Kemmerich B, Schaberg T (1992) Systemic and endotracheal antibiotic prophylaxis of nosocomial pneumonia in ICU. Intensive Care Med 18(Suppl 1):S24\u2013S27. https:\/\/doi.org\/10.1007\/BF01752973","journal-title":"Intensive Care Med"},{"issue":"8","key":"827_CR29","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1592\/phco.22.12.972.33596","volume":"22","author":"GC Wood","year":"2002","unstructured":"Wood GC, Boucher BA, Croce MA, Hanes SD, Herring VL, Fabian TC (2002) Aerosolized ceftazidime for prevention of ventilator-associated pneumonia and drug effects on the proinflammatory response in critically ill trauma patients. Pharmacotherapy 22(8):972\u2013982. https:\/\/doi.org\/10.1592\/phco.22.12.972.33596","journal-title":"Pharmacotherapy"},{"issue":"1","key":"827_CR30","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1089\/sur.2006.042","volume":"8","author":"JA Claridge","year":"2007","unstructured":"Claridge JA, Edwards NM, Swanson J et al (2007) Aerosolized ceftazidime prophylaxis against ventilator-associated pneumonia in high-risk trauma patients: results of a double-blind randomized study. Surg Infect (Larchmt) 8(1):83\u201390. https:\/\/doi.org\/10.1089\/sur.2006.042","journal-title":"Surg Infect (Larchmt)"},{"key":"827_CR31","doi-asserted-by":"publisher","unstructured":"Ehrmann S, Barbier F, Demiselle J et al (2023) Inhaled amikacin to prevent ventilator-associated pneumonia. New England J Med 389(22). https:\/\/doi.org\/10.1056\/NEJMoa2310307","DOI":"10.1056\/NEJMoa2310307"},{"key":"827_CR32","doi-asserted-by":"publisher","unstructured":"Greenfield S, Teres D, Bushnell LS, Hedley-Whyte J, Feingold DS (1973) Prevention of gram-negative bacillary pneumonia using aerosol polymyxin as prophylaxis. I. Effect on the colonization pattern of the upper respiratory tract of seriously ill patients.\u00a0J Clin Invest 52(11):2935\u20132940. https:\/\/doi.org\/10.1172\/JCI107490","DOI":"10.1172\/JCI107490"},{"key":"827_CR33","doi-asserted-by":"publisher","unstructured":"Rouby JJ, Po\u00e8te P, Martin de Lassale E et al (1994) Prevention of gram negative nosocomial bronchopneumonia by intratracheal colistin in critically ill patients. Histologic and bacteriologic study.\u00a0Intensive Care Med 20(3):187\u2013192. https:\/\/doi.org\/10.1007\/BF01704698","DOI":"10.1007\/BF01704698"},{"key":"827_CR34","doi-asserted-by":"publisher","unstructured":"Rathgeber J, Zielmann S, Panzer C, Burchardi H (1993) Pneumonieprophylaxe durch endotracheale Tobramycin-Mikroverneblung. An\u00e4sthesiol Intensivmed Notfallmed Schmerzther 28(01). https:\/\/doi.org\/10.1055\/S-2007-998870","DOI":"10.1055\/S-2007-998870"},{"key":"827_CR35","unstructured":"R Development Core Team (2024) R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. https:\/\/www.R-project.org\/"},{"key":"827_CR36","doi-asserted-by":"publisher","unstructured":"McGuinness LA, Higgins JPT (2021) Risk\u2010of\u2010bias VISualization (robvis): an R package and Shiny web app for visualizing risk\u2010of\u2010bias assessments. Res Synth Methods 12(1). https:\/\/doi.org\/10.1002\/jrsm.1411","DOI":"10.1002\/jrsm.1411"},{"key":"827_CR37","doi-asserted-by":"publisher","unstructured":"Brignardello-Petersen R, Florez ID, Izcovich A et al (2020) GRADE approach to drawing conclusions from a network meta-analysis using a minimally contextualised framework. BMJ 371. https:\/\/doi.org\/10.1136\/bmj.m3900","DOI":"10.1136\/bmj.m3900"},{"key":"827_CR38","doi-asserted-by":"publisher","unstructured":"Page MJ, Sterne JAC, Boutron I et al (2023) ROB-ME: a tool for assessing risk of bias due to missing evidence in systematic reviews with meta-analysis.\u00a0BMJ 383:e076754. Published 2023 Nov 20. https:\/\/doi.org\/10.1136\/bmj-2023-076754","DOI":"10.1136\/bmj-2023-076754"},{"key":"827_CR39","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3389\/fmed.2019.00099","volume":"6","author":"MS Niederman","year":"2019","unstructured":"Niederman MS (2019) Adjunctive nebulized antibiotics: what is their place in ICU infections? Front Med (Lausanne) 6:99. https:\/\/doi.org\/10.3389\/fmed.2019.00099","journal-title":"Front Med (Lausanne)"},{"issue":"6","key":"827_CR40","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1007\/s00134-013-2872-5","volume":"39","author":"S Ehrmann","year":"2013","unstructured":"Ehrmann S, Roche-Campo F, Sferrazza Papa GF et al (2013) Aerosol therapy during mechanical ventilation: an international survey. Intensive Care Med 39(6):1048\u20131056. https:\/\/doi.org\/10.1007\/s00134-013-2872-5","journal-title":"Intensive Care Med"},{"key":"827_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5152\/ejp.2014.00087","volume":"16","author":"A Ari","year":"2014","unstructured":"Ari A (2014) Jet, ultrasonic, and mesh nebulizers an evaluation of nebulizers for better clinical outcomes. Eurasian J Pulmonol 16:1\u20137. https:\/\/doi.org\/10.5152\/ejp.2014.00087","journal-title":"Eurasian J Pulmonol"},{"key":"827_CR42","doi-asserted-by":"publisher","unstructured":"Kalil AC, Metersky ML, Klompas M et al (2017) Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the infectious diseases society of America and the American Thoracic Society [published correction appears in Clin Infect Dis. 2017 May 1;64(9):1298. https:\/\/doi.org\/10.1093\/cid\/ciw799.] [published correction appears in Clin Infect Dis. 2017 Oct 15;65(8):1435. https:\/\/doi.org\/10.1093\/cid\/cix587.] [published correction appears in Clin Infect Dis. 2017 Nov 29;65(12):2161. https:\/\/doi.org\/10.1093\/cid\/cix759.].\u00a0Clin Infect Dis 63(5):e61\u2013e111. https:\/\/doi.org\/10.1093\/cid\/ciw353","DOI":"10.1093\/cid\/ciw799"}],"container-title":["Lung"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-025-00827-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00408-025-00827-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-025-00827-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T04:42:19Z","timestamp":1766378539000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00408-025-00827-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,5]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["827"],"URL":"https:\/\/doi.org\/10.1007\/s00408-025-00827-1","relation":{},"ISSN":["0341-2040","1432-1750"],"issn-type":[{"value":"0341-2040","type":"print"},{"value":"1432-1750","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,5]]},"assertion":[{"value":"17 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"This study is a systematic review and meta-analysis of previously published data and did not involve direct interaction with human participants or access to individual patient data. Therefore, institutional review board (IRB) approval and informed consent were not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Not applicable. This study did not involve individual human participants, and no new data were collected.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable. This manuscript does not include any individual person\u2019s data in any form.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Publish"}}],"article-number":"75"}}